bumetanide has been researched along with Colorectal Neoplasms in 1 studies
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pathogenesis for colorectal cancer remains unresolved." | 1.36 | Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia. ( Bindslev, N; Hansen, MB; Kaltoft, N; Osbak, PS; Poulsen, SS; Tilotta, MC; Witte, AB, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaltoft, N | 1 |
| Tilotta, MC | 1 |
| Witte, AB | 1 |
| Osbak, PS | 1 |
| Poulsen, SS | 1 |
| Bindslev, N | 1 |
| Hansen, MB | 1 |
1 other study available for bumetanide and Colorectal Neoplasms
| Article | Year |
|---|---|
Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
Topics: Alprostadil; Biopsy; Bumetanide; Colforsin; Colon; Colorectal Neoplasms; Dinoprostone; Female; Human | 2010 |